RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors
RUNX1-Survivin轴是恶性横纹肌样瘤的新型治疗靶点
期刊:Mol Cells
影响因子:3.700
doi:10.14348/molcells.2022.2031
Masamitsu Mikami ,Tatsuya Masuda ,Takuya Kanatani ,Mina Noura ,Katsutsugu Umeda ,Hidefumi Hiramatsu ,Hirohito Kubota ,Tomoo Daifu ,Atsushi Iwai ,Etsuko Yamamoto Hattori ,Kana Furuichi ,Saho Takasaki ,Sunao Tanaka ,Yasuzumi Matsui ,Hidemasa Matsuo ,Masahiro Hirata ,Tatsuki R Kataoka ,Tatsutoshi Nakahata ,Yasumichi Kuwahara ,Tomoko Iehara ,Hajime Hosoi ,Yoichi Imai ,Junko Takita ,Hiroshi Sugiyama ,Souichi Adachi ,Yasuhiko Kamikubo